(Bloomberg) -- Biovac, South Africa’s state vaccine company, will manufacture the Hexaxim vaccine under license from Sanofi Pasteur, marking the first manufacture of vaccines in the country since the mid 1990s.
The vaccine protects against six common diseases affecting infants, the companies said in a statement on Thursday.
